Reviva Pharmaceuticals Holdings, Inc. has announced that Armanino LLP, its current independent registered public accounting firm, will not stand for re-appointment after September 30, 2023 due to transitioning away from providing financial statement audit services to public companies. The Company's Audit Committee has initiated a process to select a new accounting firm to audit the financial statements for the fiscal year ended December 31, 2023.